-

XiFin Partners with Premier Radiology Data Intelligence Leaders Science and Medicine Group and AuntMinnie to Launch First-of-Its-Kind Radiology Research Examining Industry Challenges in 2026 and Beyond

Study to examine drivers of radiology revenue leakage and profitability; attendees can take the survey at the XiFin booth at RBMA 2026 PaRADigm April 12-15, where XiFin will also showcase its Empower AI Agentic Appeals solution

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in AI-driven revenue cycle management (RCM) solutions, today announced the launch of a first-of-its-kind Radiology Perspectives Study in collaboration with Science and Medicine Group (SMG), a premier data intelligence company, and AuntMinnie, an industry-leading radiology media and insights platform. The research is designed to examine the operational, administrative, and financial challenges facing radiology groups by gathering perspectives across roles and organizational types. The research initiative will be introduced at RBMA 2026 PaRADigm on April 12, where XiFin will also demonstrate its Empower AI RCM ecosystem, including its latest agentic AI appeals solution. The study launches at a critical time, when radiology practices are navigating mounting pressures from coverage denials, prior authorizations, staffing shortages, and technology fragmentation, even as adoption of artificial intelligence introduces new layers of complexity.

“The Radiology Perspectives Study extends beyond data collection to advance how radiology organizations understand and address the pressures shaping their operations,” said Sandra Greefkes, VP of Product and Partner Marketing at XiFin.

Share

Unlike traditional industry surveys that present a single, aggregated view, this XiFin, Science and Medicine Group, and AuntMinnie initiative is structured to capture how the same challenges are experienced differently across radiology organizations and to better understand the disconnects that drive real performance risk. By capturing perspectives across roles ranging from executive leadership to frontline staff, the research aims to pinpoint where assumptions diverge from day-to-day operational reality. Often invisible in traditional surveys, these types of gaps can contribute to margin loss, workflow breakdowns, and downstream patient impacts.

“The world of radiology is rapidly evolving, driven by reimbursement changes, staffing-related challenges including burnout and shortages, and ever-increasing imaging volumes," said Erik L. Ridley, Editor-in-Chief of AuntMinnie. "We're partnering with XiFin on this research project to identify common pain points to help radiology practices thrive in this high-pressure environment.”

The research will focus on several key areas, including:

  • Claims denials and related revenue leakage
  • Prior authorization and staff scheduling burdens
  • Staffing, burnout, and workflow productivity
  • Technology, AI, and interoperability
  • Patient financial experience

“The Radiology Perspectives Study extends beyond data collection to advance how radiology organizations understand and address the pressures shaping their operations,” said Sandra Greefkes, VP of Product and Partner Marketing at XiFin. “By bringing together perspectives that are not typically examined in parallel, the initiative is designed to identify misalignment between strategic priorities and operational execution—key drivers of inefficiency, administrative burden, and financial risk. In collaboration with Science and Medicine Group and AuntMinnie, this work establishes a foundation for insight‑driven action to help radiology practices operate with greater clarity, confidence, and resilience.”

Following completion of data collection, insights from the research will be shared through Science and Medicine Group’s editorial channels, including print coverage and a live webcast. XiFin also plans to use the findings to inform future educational resources and industry frameworks focused on improving operational alignment and financial performance across radiology organizations.

To learn more and share your voice, participate in person at XiFin booth #100 during RBMA 2026 PaRADigm, or visit www.xifin.com/auntminnie-2026-study.

About AuntMinnie

AuntMinnie.com is the premier online destination for medical imaging professionals. With a dedicated focus on advancing the field of medical imaging, AuntMinnie.com provides a platform for collaboration, education, and innovation in the industry. Our community of radiologists, researchers, and industry leaders relies on AuntMinnie.com for the latest news, expert insights, and valuable resources.

About Science and Medicine Group

Science and Medicine Group is on a mission, as a premier data intelligence company, to deliver actionable insights about hard-to-reach audiences in science and medicine. The company is actively expanding its portfolio of data intelligence solutions, building on the longstanding success of its well-known market research brands, such as Bioinformatics and Kalorama, its media sites, AuntMinnie.com, DrBicuspid.com, and The Science Advisory Board, a network of scientists immersed in biological research, drug discovery and biopharmaceutical production. The company's breadth of data-driven offerings and value creation across its world-class brands is powering customer product growth and commercialization efforts to create competitive advantages for its customers. The company is based in Arlington, VA. For more information, visit www.scienceandmedicinegroup.com.

About XiFin

XiFin is a healthcare information technology company that empowers organizations to navigate an evolving and increasingly complex healthcare landscape. The XiFin Empower AI RCM ecosystem and trusted data employ active intelligence and automation to reduce manual touches, coordinate workflows, accelerate customer innovation, and improve financial outcomes. Our comprehensive set of solutions—spanning revenue cycle management, clinical workflow enablement, laboratory information systems, and patient engagement—deliver The Power to Do Good® so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.

Contacts

Media Contact:
Peter Collins
908-499-1200
p.collins@togorun.com

XiFin, Inc.

Details
Headquarters: San Diego, CA
CEO: Lâle White
Employees: 900+
Organization: PRI

Release Versions

Contacts

Media Contact:
Peter Collins
908-499-1200
p.collins@togorun.com

Social Media Profiles
More News From XiFin, Inc.

Diagnostic Lab Claim Denials Jumped 40% in 2025, New XiFin Research Report Finds

SAN DIEGO--(BUSINESS WIRE)--Denials of clinical laboratory, molecular diagnostic, and genomics claims rose to 11.2% in 2025 from 8.0% the year before, a 40% jump that erased two years of improvement, according to the recently released 2026 Payor Denial Impact Report from XiFin, Inc., a leader in AI-enabled revenue cycle management (RCM). The report is based on an analysis of more than 30 million claims processed through XiFin’s Empower RCM solution, which serves 11 of the 15 largest laboratorie...

XiFin Launches Fourth Annual Pharmacy Transformation Outlook Survey as Legislative Action Moves to Reshape Pharmacist-Provided Care

SAN DIEGO--(BUSINESS WIRE)--In recognition of American Pharmacists Month, XiFin, Inc., a leading provider of AI-driven revenue cycle management (RCM) solutions and services to more than half of U.S. pharmacies, today opened its fourth annual Pharmacy Transformation Outlook Survey. The research will gather perspectives from pharmacy professionals on reimbursement, specialty pharmacy growth, clinical services, AI adoption, and operational barriers, and will seek to support national advocacy and in...

Frost Radar™ Recognizes XiFin as the Only AI-enabled Ancillary Healthcare RCM Specialist Among Leading North American Providers

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in AI-enabled revenue cycle management (RCM), today announced it has been recognized in the Frost Radar™: Revenue Cycle Management Operations in North America. Frost & Sullivan evaluated more than 100 companies and identified XiFin as one of only 15 providers recognized on its Growth and Innovation indices, and the only company focused exclusively on ancillary healthcare revenue cycle management. Frost & Sullivan estimates the North Amer...
Back to Newsroom